Related Experiment Videos
Improved long-term survival after aortocoronary bypass for advanced coronary artery disease
Insights
Coronary artery bypass grafting significantly prolongs life for patients with two- and three-vessel coronary artery disease. This surgical revascularization offers improved longevity compared to medical treatment alone.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Surgery
Background:
- Coronary artery disease (CAD) poses a significant health burden.
- Surgical revascularization is a treatment option for severe CAD.
- Outcomes of coronary artery bypass grafting (CABG) require ongoing evaluation.
Purpose of the Study:
- To evaluate the long-term survival rates of patients undergoing CABG.
- To compare the longevity of surgically treated patients with medically treated patients.
- To assess the impact of complete revascularization on patient survival.
Main Methods:
- Retrospective analysis of 330 patients undergoing CABG between July 1970 and March 1974.
- Life table analysis was employed for survival assessment.
- Comparison with historical data of medically treated patients with angiographically proven CAD.
Main Results:
- Operative mortality for CABG was 1.2%.
- Long-term mortality after CABG was 4%.
- Patients with two- and three-vessel CAD receiving complete revascularization showed significantly improved survival compared to medical management.
Conclusions:
- Coronary artery bypass grafting demonstrates a favorable effect on longevity in selected patients with advanced coronary artery disease.
- Complete revascularization appears crucial for maximizing survival benefits.
- Further long-term follow-up is warranted to confirm these findings definitively.
Abstract:
Three hundred thirty patients undergoing coronary bypass grafts for disabling angina, "preinfarction" angina, or coronary occlusion without cardiogenic shock have undergone coronary revascularization from July 1970 to March 1974. The operative mortality was 1.2 per cent and the long-term mortality, 4 per cent. Patients were subjected to life table analysis, and the figures suggest that in patients with two- and three-vessel coronary artery disease who received complete revascularization, there was a significant prolongation of life when compared with data from a large series of medically treated patients with angiographically documented coronary artery disease. Longer follow-up data will be important in definitively ascertaining the favorable effect of coronary revascularization on longevity.